Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles
- 21 May 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (49) , 8915-8918
Abstract
Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.Keywords
Funding Information
- Cancer Council NSW (RG 22-12)
- Australian Research Council (FT210100737)
This publication has 18 references indexed in Scilit:
- Recent advances in SERS assays for detection of multiple extracellular vesicles biomarkers for cancer diagnosisNanoscale, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Absolute Quantification of Serum Exosomes in Patients with an SERS-Lateral Flow Strip Biosensor for Noninvasive Clinical Cancer DiagnosisACS Applied Materials & Interfaces, 2023
- Rapid Evaluation of Lung Adenocarcinoma Progression by Detecting Plasma Extracellular Vesicles with Lateral Flow ImmunoassaysACS Sensors, 2023
- Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancerBMC Cancer, 2022
- Toward precision oncology: SERS microfluidic systems for multiplex biomarker analysis in liquid biopsyMaterials Advances, 2022
- Recent advances in single extracellular vesicle detection methodsBiosensors and Bioelectronics, 2020
- Liquid biopsy in breast cancer: A comprehensive reviewClinical Genetics, 2019
- Point-of-care detection of extracellular vesicles: Sensitivity optimization and multiple-target detectionBiosensors and Bioelectronics, 2017
- EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene TherapyCancer Research, 2004